Abbruzzese JL - Search Results

1

Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer.

Suzuki H, Li Y, Dong X, Hassan MM, Abbruzzese JL, Li D. Suzuki H, et al. Among authors: abbruzzese jl. Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3467-73. doi: 10.1158/1055-9965.EPI-08-0514. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 19064563 Free PMC article.

2

Phase II evaluation of iproplatin in patients with advanced gastric and pancreatic cancer.

Hubbard KP, Pazdur R, Ajani JA, Braud E, Blaustein A, King M, Llenado-Lee M, Winn R, Levin B, Abbruzzese JL. Hubbard KP, et al. Among authors: abbruzzese jl. Am J Clin Oncol. 1992 Dec;15(6):524-7. Am J Clin Oncol. 1992. PMID: 1449117 Clinical Trial.

3

Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells.

Grau AM, Zhang L, Wang W, Ruan S, Evans DB, Abbruzzese JL, Zhang W, Chiao PJ. Grau AM, et al. Among authors: abbruzzese jl. Cancer Res. 1997 Sep 15;57(18):3929-34. Cancer Res. 1997. PMID: 9307274

4

DNA adducts in human pancreatic tissues and their potential role in carcinogenesis.

Wang M, Abbruzzese JL, Friess H, Hittelman WN, Evans DB, Abbruzzese MC, Chiao P, Li D. Wang M, et al. Among authors: abbruzzese mc, abbruzzese jl. Cancer Res. 1998 Jan 1;58(1):38-41. Cancer Res. 1998. PMID: 9426054

5

bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome.

Sinicrope FA, Evans DB, Leach SD, Cleary KR, Fenoglio CJ, Lee JJ, Abbruzzese JL. Sinicrope FA, et al. Among authors: abbruzzese jl. Clin Cancer Res. 1996 Dec;2(12):2015-22. Clin Cancer Res. 1996. PMID: 9816161

6

The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.

Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ. Wang W, et al. Among authors: abbruzzese jl. Clin Cancer Res. 1999 Jan;5(1):119-27. Clin Cancer Res. 1999. PMID: 9918209

7

Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.

Bruns CJ, Harbison MT, Davis DW, Portera CA, Tsan R, McConkey DJ, Evans DB, Abbruzzese JL, Hicklin DJ, Radinsky R. Bruns CJ, et al. Among authors: abbruzzese jl. Clin Cancer Res. 2000 May;6(5):1936-48. Clin Cancer Res. 2000. PMID: 10815919

8

Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma.

Bruns CJ, Solorzano CC, Harbison MT, Ozawa S, Tsan R, Fan D, Abbruzzese J, Traxler P, Buchdunger E, Radinsky R, Fidler IJ. Bruns CJ, et al. Cancer Res. 2000 Jun 1;60(11):2926-35. Cancer Res. 2000. PMID: 10850439

9

Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma.

Wang B, Xiong Q, Shi Q, Le X, Abbruzzese JL, Xie K. Wang B, et al. Among authors: abbruzzese jl. Cancer Res. 2001 Jan 1;61(1):71-5. Cancer Res. 2001. PMID: 11196200

10

Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma.

Shi Q, Le X, Abbruzzese JL, Peng Z, Qian CN, Tang H, Xiong Q, Wang B, Li XC, Xie K. Shi Q, et al. Among authors: abbruzzese jl. Cancer Res. 2001 May 15;61(10):4143-54. Cancer Res. 2001. PMID: 11358838

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

502 results

Search Page

Filters